Search

Displaying results 41 - 50 of 53 in total
  1. Indication

    Upper Limb Spasticity

    go.drugbank.com/conditions/DBCOND0036871
    Drugs: Botulinum toxin type A · Clostridium botulinum
  2. Indication

    Strabismus, Noncomitant

    go.drugbank.com/conditions/DBCOND0157106
    Drugs: Botulinum toxin type A · Homatropine
  3. Indication

    Sialorrhea

    go.drugbank.com/conditions/DBCOND0001979
    Drugs: Botulinum toxin type A · Glycopyrronium
  4. Indication

    Spasticity

    go.drugbank.com/conditions/DBCOND0020611
    Drugs: Baclofen · Botulinum toxin type A · Dantrolene · Tolperisone
  5. Indication

    Diabetic Neuropathies

    go.drugbank.com/conditions/DBCOND0028190
    Drugs: Amitriptyline · Botulinum toxin type A · Citalopram · Cyanocobalamin · Desipramine · Lipoic acid +1 more
  6. Indication

    Overactive Bladder Syndrome (OABS)

    go.drugbank.com/conditions/DBCOND0036138
    Drugs: Botulinum toxin type A · Darifenacin · Fesoterodine · Imidafenacin · Mirabegron · Oxybutynin +3 more
  7. Indication

    Postherpetic Neuralgia

    go.drugbank.com/conditions/DBCOND0029450
    Drugs: Botulinum toxin type A · Clonidine · Desipramine · Gabapentin · Gabapentin enacarbil · Lidocaine +5 more
  8. Indication

    Epicondylitis

    go.drugbank.com/conditions/DBCOND0015538
    Drugs: Betamethasone · Betamethasone phosphate · Botulinum toxin type A · Bupivacaine · Cortisone acetate · Dexamethasone +5 more
  9. Pathway

    Sphingolipid Signaling (Receptor)

    smpdb.ca/view/SMP0524344
    Signaling

    Sphingosine‑1‑phosphate (S1P) is a potent bioactive lipid mediator synthesized intracellularly by the phosphorylation of sphingosine by sphingosine kinases SphK1 and SphK2 at the plasma membrane and is … activation, Rho GTPase–driven cytoskeletal remodeling, and PI3K/Akt and MAPK pathways—S1P orchestrates context‑dependent outcomes such as migration, proliferation, contraction, or cytoskeletal organization in a

    Drugs: Nitric Oxide · Calcium · Magnesium cation
    Enzymes: Ras-related C3 botulinum toxin substrate 2, Ras-related C3 botulinum toxin substrate 3
  10. Pathway

    Mercaptopurine Action Pathway

    smpdb.ca/view/SMP0000428
    Drug action

    , inhibition of de novo synthesis of purine nucleotides, and inhibition of Ras-related C3 botulinum toxin substrate 1, which induces apoptosis of activated T cells. … The thioguanosine triphosphate metabolite also inhibits Ras-related C3 botulinum toxin substrate 1, a plasma membrane-associated small GTPase that regulates cellular processes, inducing apoptosis in activated

    Drugs: Tetrahydrofolic acid · Ademetionine · Aspartic acid · L-Glutamine · Adenosine phosphate · Glutamic acid +26 more
    Enzymes: Ras-related C3 botulinum toxin substrate 1, Adenylate cyclase type 10